ANVISA registration 82195300013ActiveSELF-TEST FOR HUMAN CHORIONIC GONADOTROPIN (HCG)
ANVISA Registration Number: 82195300013PURE LATAM BRAZIL COMERCIO DE PRODUTOS HOSPITALARES LTDAACMEX BIO-TECHNOLOGY (CHONGQING) CO., LTD.Risk Class II
Device names
- Technical name
- SELF-TEST FOR HUMAN CHORIONIC GONADOTROPIN (HCG)
- Commercial name
- Teste Rápido Ultrassensível no Início da Gravidez (HCG)
- Risk class
- Class II
PT: AUTOTESTE PARA GONADOTROFINA CORIÔNICA HUMANA (HCG)
Registration details
- Registration Number
- 82195300013
- Process Number
- 25351423608202435
- CNPJ
- 27939884000109
Company information
- Registration Holder
- PURE LATAM BRAZIL COMERCIO DE PRODUTOS HOSPITALARES LTDA
- Manufacturer
- ACMEX BIO-TECHNOLOGY (CHONGQING) CO., LTD.
- Manufacturing Country
- China
PT: CHINA, REPÚBLICA POPULAR
Dates and status
- Publication Date
- Jan 13, 2025
- Status
- Active
- Last Updated
- 08/19/2026 19:00:01
Official value: VIGENTE
About this record
Access comprehensive regulatory information for SELF-TEST FOR HUMAN CHORIONIC GONADOTROPIN (HCG) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 82195300013 and manufactured by ACMEX BIO-TECHNOLOGY (CHONGQING) CO., LTD.. The registration is held by PURE LATAM BRAZIL COMERCIO DE PRODUTOS HOSPITALARES LTDA with validity until currently active (VIGENTE).
This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.